Abstract. FOXL2 is a putative transcription factor involved in ovarian development and function. Its mutations in humans are responsible for the blepharophimosis syndrome, characterized by eyelid malformations and premature ovarian failure (POF). Here we have performed a comparative sequence analysis of FOXL2 sequences of ten vertebrate species. We demonstrate that the entire open reading frame (ORF) is under purifying selection leading to strong protein conservation. We also review recent data on FOXL2 transcript and protein expression. FOXL2 has been shown 1) to be the earliest known sex dimorphic marker of ovarian determination/differentiation in vertebrates, 2) to have, at least in mammals, an ovarian expression persisting until adulthood. The conservation of its sequence and pattern of expression suggests that FOXL2 might be a key factor in the early development of the vertebrate female gonad and involved later in adult ovarian function. Finally, we provide arguments for the existence of an alternative transcript in rodents, that may arise from a differential polyadenylation. Although it has only been demonstrated in rodents, its presence/absence in other species deserves further investigation.
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FOXL2 is a putative winged helix/forkhead transcription factor gene (MIM 605597) involved in ovarian development and function. Its dominant mutations have recently been shown to be responsible for the blepharophimosis syndrome (or BPES for Blepharophimosis Ptosis Epicanthus inversus Syndrome, MIM 110100) a rare genetic disease characterized by eyelid malformations associated with premature ovarian failure (POF) (BPES type I) or occurring isolated (BPES type II) (Zlotogora et al., 1983; Crisponi et al., 2001; De Baere et al., 2001) . Until now, no clear-cut pathogenic mutations have been found in patients affected with isolated POF Harris et al., 2002) .
As a member of the large family of winged helix/forkhead transcription factors, FOXL2 contains a characteristic 110-amino acid DNA-binding domain, the forkhead. Many forkhead proteins are known to be involved in different developmental and metabolic processes (Kaufmann and Knöchel, 1996; Carlsson and Mahlapuu, 2002) and mutations in some of them are responsible for genetic developmental diseases (Carlsson and Mahlapuu, 2002) . FOXL2 also contains a polyalanine tract (polyAla), whose role (if any) has not been identified yet. Expansions from 14 to 24 alanine residues in this region represent 30 % of all FOXL2 mutations detected in the ORF and lead mainly to BPES type II .
The nucleotide and amino acid sequences of FOXL2 in four vertebrates, ranging from fish to man, have previously been compared and shown to be highly conserved (Cocquet et al., Table 1 . Estimated ratio of synonymous (dS) and non-synonymous (dN) substitution rates obtained using the CODEML program in the PAML package (lower matrix, Yang, 2002 The expression of FOXL2 has already been studied extensively by us and others, in mammals (Crisponi et al., 2001; Cocquet et al., 2002) as well as in non-mammalian vertebrate species (Loffler et al., 2003) . Here, we review recent data on FOXL2 mRNA and protein pattern of expression and also provide novel data on protein expression in the human developing eyelid and peri-ocular muscles.
In addition, we provide evidence for the existence of a second alternative transcript in rodents, which is likely to result from a differential polyadenylation. Our results strongly suggest that this second transcript contains the entire Foxl2 ORF.
FOXL2 protein sequence is highly conserved
In a previous study, we have demonstrated that the FOXL2 protein is highly conserved in four species (human, goat, mouse and pufferfish) and is under a purifying selection (Cocquet et al., 2002) . We aimed to extend our study by performing an analysis in other mammalian and non-mammalian sequences. FOXL2 sequences for Homo sapiens (human), Capra hircus (goat), Mus musculus (mouse), Rattus norvegicus (rat) and Fugu rubripes (pufferfish) were collected or assembled from GenBank (AI: AF301906, AY112725, AF522275, AC105826 and Scaffold-8165/ProtJGI-24134, respectively). The Danio rerio (zebrafish) and Tetraodon nigroviridis (tetraodon) sequences were obtained from public genome resources by interrogating them with the pufferfish Foxl2 sequence. Sus scrofa (pig), Oryctolagus cuniculus (rabbit), Bos taurus (cow) and Macropus eugenii (tammar wallaby) sequences were directly obtained by PCR on genomic DNA using the primers described previously (pBAD-FOXL2F and pBAD-FOXL2R; Cocquet et al., 2002) and the primer FOXL2-R420: 5) CTC GAA CAT GTC PyTC GCA GGC CGG GTC 3) (AI: AY340971 for S. scrofa, AY 340972 for O. cuniculus, AY340970 for B. taurus and AY 340969 for M. eugenii).
We have previously used Li's method to compare the FOXL2 coding sequence among different species (Li, 1993; Cocquet et al., 2002) . However, a statistically more justifiable method to calculate the rate of synonymous substitutions (dS) (i.e. when a change in the nucleotide sequence does not lead to a change in the corresponding amino acid) and non-synonymous (dN) substitutions between a pair of homologous sequences is the maximum likelihood method implemented in the CODEML program of the PAML package (Yang and Bielawski, 2000; Yang, 2002; Xia 2001) . We used therefore this method to compare FOXL2 nucleotide and protein sequences in all the above mentioned species. The ratio dN/dS is a good indicator of the selective pressure at the protein level: dN/dS = 1 implies no selection; dN/dS ! 1, a purifying selection; and dN/dS 1 1, a positive selection (Yang and Bielawski, 2000) .
Pairwise comparisons resulted in low dN/dS ratios confirming that FOXL2 is under a strong purifying selection throughout evolution (Table 1) . We also calculated the genetic distances based on dN and dS results (t, Table 1 ). Interestingly, the multiple alignment of the protein sequences shows that homopolymeric runs of amino acids are not conserved among species, in contrast with the high conservation of the rest of the protein (Fig. 1) . Indeed, in the seven eutherian mammals studied, the length of the polyalanine region is strictly conserved (i.e. 14 residues) whereas in the three fish species this domain is absent. This suggests that the polyAla tract length in mammals is under strong constraints limiting its maximum length to 14 residues. This view is supported by the deleterious effect of its expansion in the blepharophimosis syndrome (30 % of reported mutations, De . The aforementioned constraints are probably structural rather than functional, as several studies have shown that alanine runs present in mammalian genes are absent or shortened in non-mammalian homologues (Nakachi et al., 1997; Cocquet et al., 2003) . However, the polyAla tract might tune transcription factor activity (Nakachi et al., 1997; Cocquet et al., 2003) with 14 Ala residues being the optimum length for FOXL2 function in mammals. This would explain why the polyAla tract, when present, is always (as far as observed) composed of 14 residues. Interestingly, an isolated POF case carrying a FOXL2 allele with a shorter polyAla 
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-------------HAQQLSPATAAAPPVTTGNGTGLQFACSRQPAELSMMHCSYWDHESKHSALHARIDI …………………………………………………………******…*……………………******…***…*……*******…*……*…………*…*…*… stretch has been reported (Harris et al., 2002) but further studies are required to establish a formal link between polyAla contraction and isolated POF. Other amino acid repeats in FOXL2 (such as proline [Pro] , glycine [Gly]) have unequal lengths in mammals and are absent in fishes. In a recent genomic study, we have shown that human proteins containing polyAla tracts have a tendency to carry runs of other amino acids, encoded, as alanine, by GC-rich codons (i.e. Gly, Pro and histidine [His] ). Besides, the Ala, Gly, Pro and His contents of these proteins are correlated with the GC contents of the third codon base, suggesting that their amino acid composition reflects the constraints operating on the genomic compartments in which their ORFs lie (i.e. isochores) . Compositional constraints acting on the FOXL2 ORF may be different between mammals and fishes and could explain the differences of amino acid runs that we have observed.
Our analysis also reveals that the N-terminal region of FOXL2 (the first 45 amino acids) is less conserved than the C-terminal region, when excluding low complexity repeats (i.e. homopolymeric runs). Note that, in the latter region, most of amino acid changes are highly conservative. Thus, the N-terminal region might be responsible for functional differences among species or has a less important role (if any) in FOXL2 function. On the contrary, the well-conserved C-terminal region might contain yet unidentified functional domain(s).
We focused then on the forkhead domain, including the sequences of the horse (Equus caballus), obtained by PCR as previously described, the chicken (Gallus gallus) and the turtle (Trachemys scripta) (respective AI: AY155534 and AY155535). We found that the amino acid sequence is identical among eutherian mammals and that only a few minor changes, at three sites, exist when we extend the comparison to other vertebrates (alignment available from authors upon request). These changes concern amino acids that are not charged and thus do not disturb the global isoelectric point of the forkhead domain, estimated to be 10.87 in all the studied species. This highly basic isoelectric point has to be correlated with the DNA-binding activity of this domain.
The sequence and properties of FOXL2 forkhead domain are highly conserved, which is a general characteristic of forkhead transcription factors (Carlsson and Mahlapuu, 2002) .
FOXL2 pattern of expression
The pattern of expression of FOXL2 has already been studied at both the mRNA and protein levels in different species and has provided interesting insights. In human, mouse and goat FOXL2 has only been detected in developing eyelids and in fetal and adult ovaries while it has not been detected in testis at any stage. Its protein localization has been shown to be nuclear, which is in line with its putative function as a transcription factor (Crisponi et al., 2001; Cocquet et al., 2002) .
Here, we provide data on FOXL2 protein expression in human developing eyelids: as shown in Fig. 2 , it is located in a wide region of the primordial mesenchyma of the developing eyelids. Magnetic resonance imaging (MRI) performed on the orbit of BPES patients has revealed the absence or hypotrophy of the eyelid superior levator muscle (Dollfus et al., 2003) . The authors have suggested that FOXL2 may be involved in the development of this muscle. However, the much wider expression domain of the protein (in the bulging and surrounding primordial mesenchyma, Fig. 2 ) also suggests a role in the development of other peri-ocular muscles, which is supported by their same mesodermal origin and the relatively frequent observation of strabismus in BPES patients (Oley and Baraitser, 1988; Barishak et al., 1992) .
FOXL2 ovarian expression in mammals begins early in development, before the onset of folliculogenesis, and persists until adulthood. It is restricted to the somatic compartment: the follicular (granulosa) cells display a strong protein expression, the stromal cells a more diffuse one, whereas in the oocytes no signal has been observed (Cocquet et al., 2002; Pannetier et al., 2003) . The staining of the mouse stromal cells is almost undetectable, in line with the RNA in situ hybridization results of Crisponi et al. (2001) . In a recent study, Foxl2 mRNA has been observed in both granulosa cells and some oocytes of fetal and adult mouse ovaries (Loffler et al., 2003) . Low levels of FOXL2 transcript have been detected in goat and mouse testis, at fetal and adult stages, but no protein could be found in any of those tissues (Pailhoux et al., 2001; Cocquet et al., 2002; Pannetier et al., 2003) . Thus, either the levels of transcript are too weak to be significant, or its expression undergoes a posttranscriptional or translational regulation. One of these hypotheses may also explain the presence of Foxl2 transcript in some mouse oocytes where the protein remains undetectable. Immunohistochemistry performed with anti-C-terminal FOXL2 antibody on human developing eyelid section (7th week, Carnegie stage 19) as previously described (Cocquet et al., 2002) . FOXL2 is expressed in the bulging and surrounding primordial mesenchyma suggesting a role in the development of extra-ocular muscles consistent with the BPES phenotype (Oley and Baraitser, 1988) . Interestingly, mouse Foxl2 transcript (previously named PFrk for Pituitary forkhead factor) is also expressed in the pituitary Rathke's pouch (Treier et al., 1998) and has thus been suggested to be involved in pituitary organogenesis. Recently, protein expression has been shown to be consistent with these results (Buffy Ellsworth, personal communication).
Many forkhead proteins are responsible for differentiation processes during development and are later recycled to control metabolism in the adult (Carlsson and Mahlapuu, 2002) . The ovarian somatic expression of FOXL2 in mammals beginning at an early stage of development and persisting in adult life suggests a similar dual role: at first, in the ovarian somatic cell determination/differentiation and later, in maintenance of the adult ovarian function.
In non-mammalian vertebrates, Foxl2 mRNA has also been shown to be expressed at an early stage in the developing female gonad and to have a sex-dimorphic expression. In the chicken, it is expressed in the two ZW (female) gonads at early stages of development (at least from day 5 to 8) whereas no expression was found in male gonads at the same stages. In the turtle, a species undergoing temperature-dependent sex determination, Foxl2 is expressed in the developing gonads at a higher level at female than male promoting temperatures (Loffler et al., 2003) .
The conservation of FOXL2 sequence and pattern of expression throughout evolution leads to the conclusion that it is, by now, the earliest known sex-dimorphic marker of ovarian determination/differentiation in vertebrates and might be a key gene in early development and maintenance of the vertebrate female gonad.
Rodents possess alternative Foxl2 transcripts
The previous discussion demonstrates a strong conservation of FOXL2 sequence and pattern of expression among different species. Nevertheless, when exploring the GenBank expressed sequence tag (EST) division, we found a potentially interesting difference between rodents and other species: at least in mouse and rat there may be two alternative Foxl2 transcripts. Several ESTs, carrying a standard polyadenylation signal (AAUAAA), were found to end as expected from the comparison with the human sequence (for the mouse BG071987, AU046041, AU045768, AU045128, BB334136, for the rat AA850108). However we also detected other ESTs that run beyond this point in both rodents. In mouse ESTs BB556269, AW558663, BG076281, BB441670 are representative of this "longer" transcript, carrying a putative polyadenylation signal (AATA-TAAA) while for the rat ESTs, BU758851 and AI556368 would carry another non-canonic AAGAAT signal. These potential polyadenylation sites are located about 430 bp downstream of the known one. The perfect alignment of these ESTs with the genomic sequences suggests that these alternative transcripts would result from a differential polyadenylation. To explore this observation experimentally, we performed RT-PCR experiments using primers specific for this putative alternative transcript: mFoxl2polyAde-F (5) GAACTAGAG-CACTTTTGTTGT 3)) located 59 bp upstream of the first polyadenylation signal and mFoxl2polyAde-R (5) CACCTAG-TACAATTATGTAAGAG 3)) located 350 bp downstream. These experiments were conducted on cDNA from mouse gonads at different developmental stages (normalized with respect to ß actin, as in Pannetier et al., 2003 , in this issue) and on a mouse granulosa cell line (AT29C-U493, described by Dutertre et al., 2001 ). The Foxl2 second transcript was detected in female gonads, from 15.5 days post coitum (dpc) with an increasing level and persisting at adulthood. In male gonads, very faint levels were observed (Fig. 3A) . The results obtained for the Foxl2 ORF amplification were very similar, with the exception that it could be faintly detected in female gonads at 12 dpc (Fig. 3A , in line with the results obtained by Pannetier et al., 2003) . This correlation between the profiles of the ORF and the second transcript suggests that the latter encompasses the Foxl2 ORF. This is further suggested by the existence of an amplicon running from the beginning of the Foxl2 ORF to the end of the second transcript, obtained with adult mouse ovary cDNA (Fig. 3B) . This implies that the Foxl2 ORF amplifications represent, in fact, both transcripts (Fig. 3A) .
The experiments described previously have shown the presence of Foxl2 transcript and protein in the follicular cells (i.e. granulosa) of adult mouse ovaries. Interestingly, by RT-PCR we have not detected the second transcript in the mouse granulosa cell line AT29C, while the first one was detected (Fig. 3A) . Either this may be a specificity of this cell line or may be due to the fact that the second transcript is not expressed in the granulosa but in another ovarian compartment. Further studies are required to evaluate the potential existence of other alternative transcripts. For instance, rat EST AW920539 would represent an even shorter transcript, if artifactual RT-priming is ruled out (since there is a polyadenylate stretch immediately downstream of the AAUAAA site). Indeed this polyadenylation site (F770 bp downstream of the stop codon) is the optimum recognized by the Genscan program in human, rat and mouse. ESTs BG088806 and BF544943, among others, seem to start downstream of the Foxl2 stop codon (more details in a manuscript in preparation). It would be interesting to assess whether the existence of alternative transcripts has a functional significance or not.
Besides, although a similar region exists in human, there is no EST-based evidence of the existence of a longer human transcript. This is consistent with Northern blot experiments on human ovary RNA where only one FOXL2 transcript has been detected (Crisponi et al., 2001 ). However, the presence/ absence of an alternative transcript in human and other species deserves more in-depth studies. This might be relevant to understanding FOXL2 function. Further studies in animal models, such as a conditional knock-out mouse model for Foxl2 might allow us to shed light on potential species-specific differences, and also on the implication of FOXL2 in early ovarian development and later during adult female life.
